"10.1371_journal.pone.0060113","plos one","2013-04-02T00:00:00Z","Dione T Kobayashi; Jing Shi; Laurie Stephen; Karri L Ballard; Ruth Dewey; James Mapes; Brett Chung; Kathleen McCarthy; Kathryn J Swoboda; Thomas O Crawford; Rebecca Li; Thomas Plasterer; Cynthia Joyce; the Biomarkers for Spinal Muscular Atrophy Study Group; Wendy K Chung; Petra Kaufmann; Basil T Darras; Richard S Finkel; Douglas M Sproule; William B Martens; Michael P McDermott; Darryl C De Vivo; the Pediatric Neuromuscular Clinical Research Network; Michael G Walker; Karen S Chen","Spinal Muscular Atrophy Foundation, New York, New York, United States of America; Walker Bioscience, Carlsbad, California, United States of America; Myriad RBM, Austin, Texas, United States of America; Departments of Neurology and Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, United States of America; Departments of Neurology and Pediatrics, Johns Hopkins University, Baltimore, Maryland, United States of America; New England Research Institutes, Watertown, Massachusetts, United States of America; BG Medicine, Waltham, Massachusetts, United States of America; The Pediatric Neuromuscular Clinical Research Network, New York, New York, United States of America","Â¶ Membership of the Biomarkers for Spinal Muscular Atrophy Study Group is provided in the Acknowledgments.","MGW and JS are employees/owners of Walker Biosciences statistical consulting group. LS, KB, RD and JM are employees of Myriad RBM, a for-profit company involved in producing research diagnostics. Myriad RBM sells the SMA-MAP panel. RL is a former employee of NERI, a for-profit clinical research organization. TP is the former employee of BG Medicine, a for-profit company involved in producing research diagnostics. RSF receives commercial research support from PTC Therapeutics, Santhera Pharmaceuticals, and Genzyme Corp., accepted travel stipends as part of grants from PTC Therapeutics, reviewed and prepared a report for Adibi legal proceeding, spends 50% of his professional time carrying out clinical studies, and serves on the medical advisory board of DuchenneConnect and Families of SMA and on the scientific advisory board of PTC Therapeutics. TOC serves on the medical and scientific advisory boards of Families of SMA, the medical board of the Muscular Dystrophy Association, and has served as frequent ad hoc advisor to the Scientific Advisory Board of the SMA Foundation. KJS serves on the scientific advisory boards of Families of SMA, the Pediatric Neurotransmitter Disorders Foundation, California Stem Cell, Inc., and the Alternating Hemiplegia of Childhood Foundation (AHCF). She serves as an ad-hoc reviewer for the Muscular Dystrophy Association (MDA) and National Institutes of Health (NIH). She has accepted research funds for consultation for Biomarin Pharmaceuticals and Shire, Inc. The SMA Foundation has filed a patent application on aspects of this work, International Patent Application No. PCT/US2010/048675, and Ref: SMAF- 005/01WO 304991-2019. A member of RSFs immediate family receives commercial research support from Merck Pharmaceuticals, has received license fee payments from Southern Biotechnology Associates, Upstate Pharmaceuticals, and Santa Cruz Biotechnology, holds 6 patents or pending patents, contributes to other clinical research as a local co-investigator or PI in studies funded by the NIH and the UK, is the editor of Janeway Textbook of Immunology and Arthritis Research and Therapy, and devotes 33% of her professional time to clinical studies in her practice. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","04","Dione T Kobayashi","DTK",25,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
